New Republic Capital’s Novo Nordisk NVO Stock Holding History

New Republic Capital’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$369K	Buy	+7,689	New	+$330K	0.08%	180
2026 Q1	–	Sell	-8,669	Closed	-$441K	–	362
2025 Q4	$441K	Buy	+8,669	New	+$443K	0.12%	160
2025 Q2	–	Sell	-3,066	Closed	-$216K	–	260
2025 Q1	$216K	Sell	3,066 -611	-17%	-$50.5K	0.09%	159
2024 Q4	$316K	Buy	3,677 +1,261	+52%	+$136K	0.21%	109
2024 Q3	$288K	Sell	2,416 -421	-15%	-$56.1K	0.17%	120
2024 Q2	$405K	Buy	2,837 +267	+10%	+$35.4K	0.2%	98
2024 Q1	$330K	Buy	2,570 +176	+7%	+$21K	0.21%	98
2023 Q4	$248K	Buy	+2,394	New	+$237K	0.18%	128

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

New Republic Capital's NVO Position: Q2 2026 in Review

New Republic Capital opened a new position in Novo Nordisk (NVO) in Q2 2026: 7,689 shares worth $369K. The stake represents 0.08% of the portfolio and ranks #180 among its holdings. This is a return to the name: New Republic Capital previously reported a position in NVO as recently as Q4 2025.

New Republic Capital first reported a position in NVO in Q4 2023 and has held it in 8 quarters since. The position peaked at $441K in Q4 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

New Republic Capital held 7,689 shares of Novo Nordisk worth $369K as of Q2 2026.
Novo Nordisk was a new New Republic Capital position in Q2 2026.
Novo Nordisk made up 0.08% of New Republic Capital's portfolio in Q2 2026, its #180 holding.
New Republic Capital first reported a position in Novo Nordisk in Q4 2023 and has held it in 8 quarters since.
New Republic Capital's Novo Nordisk position peaked at $441K in Q4 2025.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.